Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cardiac safety of Trastuzumab BS "Daiichi Sankyo" vs Herceptin using claims database
jRCT2031220642Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Apr 2008
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Trial of trastuzumab in breast cancer and gastric cancer (GC) (2 cohorts), sponsored by Daiichi Sankyo Co., Ltd. Primary endpoint: Occurrence of heart disorder. Started Apr 2008; status: completed.
02
Drugs
03
Conditions
breast cancergastric cancer (GC)
Beyond the preview
Go deeper on jRCT2031220642.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031220642.